Jim Cramer says Big Tech firms need to ‘change the way they operate’ to stay market leaders

Jim Cramer says Big Tech firms need to ‘change the way they operate’ to stay market leaders


Jim Cramer says Big Tech firm need to 'change the way they operate' to stay market leaders

CNBC’s Jim Cramer on Wednesday said that some of the biggest tech companies in the world need to adjust to the changing market.

“It’s time to recognize that FAANG names got too big. Can they turn things around? Sure, but they’ve really got to change the way they operate,” he said, referring to his acronym for Facebook-parent Meta, Amazon, Apple, Netflix and Google-parent Alphabet.

Cramer previously said that financial stocks could overtake tech stocks as the new market leaders in the current high-interest-rate environment. Banks benefit from higher interest rates because they can earn more on loans.

High-growth tech companies such as FAANG names, meanwhile, are hurt by higher interest rates because their stocks trade on the promise of higher returns down the line — a risk that investors typically aren’t willing to take in a turbulent economic environment.

Cramer’s comment comes on the heels of several disappointing earnings results from Big Tech firms. Alphabet missed third-quarter revenue and profit expectations on Tuesday, while Microsoft issued weak quarterly guidance that weighed down its stock.

Meta Platforms reported a wide miss on third-quarter earnings after the close on Wednesday, which sent its stock tumbling over 18% in after-hours trading.

Netflix has fared better than its tech peers, reporting a third-quarter top-and-bottom beat on Oct. 18 along with substantial subscriber growth. The company also provided updates on its plans to crack down on password sharing and introduce a new ad-supported tier.

Cramer said that the streaming giant’s plans for the latter initiative exemplify the type of innovation FAANG companies need to stop their downward trajectory.

“Forget being leaders — Big [Tech] stocks are now followers in a post-Covid era where we’re learning that their earnings were far more inflated by the pandemic than we knew,” he said.

Amazon is slated to report its third-quarter earnings on Thursday.

Disclaimer: Cramer’s Charitable Trust owns shares of Alphabet, Apple, Amazon, Meta and Netflix.

Jim Cramer on why FAANG companies are losing their position as market leaders

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.  In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Read More
Seattle Seahawks begin sale process after Super Bowl win
Business

Seattle Seahawks begin sale process after Super Bowl win

Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington. Jane Gershovich | Getty Images The Seattle Seahawks are officially up for sale. The NFL team, which defeated the New England […]

Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive
Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned.  In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]

Read More